Ownership history in MACQUARIE GROUP LTD · 39 quarters on record
This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in ACADIA PHARMACEUTICALS INC (ACAD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 92,648 | — | 0% | 0.00% | $2.0M | $21.34 |
| 2025 Q2 | UNCHANGED | 92,648 | — | 0% | 0.00% | $2.0M | $21.57 |
| 2025 Q1 | REDUCED | 92,648 | -11,500 | -11.0% | 0.00% | $1.5M | $16.61 |
| 2024 Q4 | ADDED | 104,148 | +11,500 | +12.4% | 0.00% | $1.7M | $18.35 |
| 2024 Q3 | UNCHANGED | 92,648 | — | 0% | 0.00% | $1.4M | $15.38 |
| 2024 Q2 | REDUCED | 92,648 | -374,807 | -80.2% | 0.00% | $1.5M | $16.25 |
| 2024 Q1 | ADDED | 467,455 | +379,807 | +433.3% | 0.01% | $8.6M | $18.49 |
| 2023 Q4 | REDUCED | 87,648 | -72,352 | -45.2% | 0.00% | $2.7M | $31.31 |
| 2023 Q3 | UNCHANGED | 160,000 | — | 0% | 0.00% | $3.3M | $20.84 |
| 2023 Q2 | UNCHANGED | 160,000 | — | 0% | 0.00% | $3.8M | $23.95 |
As of 2025 Q4 — sorted by position size